HOME >> BIOLOGY >> NEWS
Leibniz Prize winners 2003

cal Cytobiology and Cytopathology at the Philipps University in Marburg.

Prof. Dr. Christof Niehrs (40), development biology/genetics/zoology, German Cancer Research Centre in Heidelberg (1.55 million euros)

Christof Niehrs is well-known around the world as the development biologist who has answered many of the central questions in his field. His answers, together with an understanding of the underlying genomes, have laid the foundations for future contributions to questions which have not yet been answered, such as the question of shape and size in biology. Christof Niehrs has made his name in three fields of research:

    For studying mesoderm formation in amphibians (xenopus) he developed a gene expression screen for analysing gene activity in xenopus embryos. In the course of this research a number of control genes were identified which play a part in the development of the embryo.

    A second key focus of Niehrs' work relates to the Spemann organiser function, a piece of tissue from the amphibian embryo which has the power to induce a complete new embryo following transplantation.

    Possibly the most spectacular work presented by Christof Niehrs has been on the development mechanism of the embryo's head; this work has helped to solve one of the central problems which hampered even Spemann's research results.

Christof Niehrs studied biochemistry at the Free University of Berlin. After obtaining his doctorate there he moved to a postdoctoral post at the University of California in Los Angeles. In the years following 1994 he developed his own study group at the German Cancer Research Centre in Heidelberg. Following his qualification as a university professor in 1997, at the age of 36 he was offered a C4 professorship in biochemistry at the University of Bochum. Since then he has been offered professorships at the University of Karlsruhe and at the German Cancer Research Centre in Heidelberg.

Prof. Dr. Fer
'"/>

Contact: Ursula Rogmans-Beucher
ursula.rogmans-beucher@dfg.de
49-228-885-2726
Deutsche Forschungsgemeinschaft
3-Apr-2003


Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology news :

1. Leibniz Prizewinners 2004
2. Prizes awarded in the 2002 Gottfried Wilhelm Leibniz Programme
3. Leibniz Prize Winners 1999 - Most Highly Endowed German Promotional Prize For Ten Scientists
4. Half-million dollar landmark achieved for the Methuselah Mouse Prize
5. Winner of 2004 EMBO Science Writing Prize announced
6. Fox Chase Cancer Centers Alfred Knudson Jr. named 2004 Kyoto Prize winner
7. Stuart Lipton honored with Jung Prize for Medicine
8. 2004 Max Planck Research Prize for Martin Vingron and Eugene W. Myers
9. Scripps research scientist wins 2004 Koch Prize
10. Ohio State wetlands professor wins prestigious Water Prize
11. Tony Hunter and Raymond N. DuBois awarded Landon-AACR Prizes for Cancer Research

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Leibniz Prize winners

(Date:8/22/2014)... the birds and the bees. But that old ... fertilized. The fertilization process for flowering plants is ... male and female reproductive cells. New research from ... Munich, and including Carnegie,s Wolf Frommer, David Ehrhardt, ... signaling process that guides flowering plant fertilization. It ...
(Date:8/21/2014)... -- Nxt-ID, Inc. (OTCQB: NXTD), a biometric authentication company ... that its shares of common stock and the warrants ... proposed underwritten public offering of common stock and warrants ... Market, subject to closing of its proposed underwritten public ... trade under the symbol "NXTD" and "NXTDW," respectively. ...
(Date:8/21/2014)... Aug. 21, 2014 /PRNewswire-iReach/ -- LiveScan Service ... agreed to a partnership with Gabriel Health Institute, ... fastest growing Certified Nursing Assistant preparatory schools. ...  an exclusive member of Binary,s LiveScan service provider,s ... will improve its service capabilities by widening ...
Breaking Biology News(10 mins):Calcium and reproduction go together 2Nxt-ID Approved for NASDAQ Capital Market Listing 2Nxt-ID Approved for NASDAQ Capital Market Listing 3LiveScan Provider Binary Biometrics Announces Partnership with Preeminent CNA School, Gabriel Health Institute to Expand Services in Orlando Region 2LiveScan Provider Binary Biometrics Announces Partnership with Preeminent CNA School, Gabriel Health Institute to Expand Services in Orlando Region 3
(Date:8/21/2014)...  BioSpecifics Technologies Corp. (NASDAQ: BSTC ... collagenase-based products marketed as XIAFLEX ® (collagenase ... XIAPEX ® in the EU, today announced ... Phase 2a study of CCH for the potential ... results showed that all three doses of CCH ...
(Date:8/21/2014)... DUBLIN, Ireland , August 21, 2014 ... and Markets ( http://www.researchandmarkets.com/research/3zh3q8/global_hormone ) has announced the ... Market 2014-2018"  report to their offering.  ... also known as hormone therapy, is a ... longer being produced by the body. This ...
(Date:8/21/2014)... NEW YORK , Aug. 21, 2014 Mathematic ... at Harvard University , and funded by the ... aggressive cells within tumors can be visually identified for elimination. ... tumor,s growth. The study, which shows a topological map of ... needed time in cancer research, for while tumor cells can ...
(Date:8/21/2014)... Ontotext S4 , The Self ... . Now the same enterprise hardened text mining, ... unstructured data is available to start-ups and mid-size businesses ... Organizations that do not have resources to evaluate and ... S4 since there is no need for on premise ...
Breaking Biology Technology:BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 2BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 3BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 4BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 5Global Hormone Replacement Therapy Market 2014-2018: Key Vendors are Actavis, Bayer, Merck & Co, Novartis and Novo Nordisk 2Science Power Jeffrey Epstein and Harvard University Fund Project to Visually Stop Tumor Growth 2Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 2Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 3Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 4
Cached News: